A

Ambrx

90 employees

Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma
Life Science

Date founded

2003

Funding rounds raised

Total raised

$200M

from 27 investors over 27 rounds

A

Ambrx raised $200M on November 9, 2020

Investors: Adage Capital Management and Suvretta Capital Management LLC

A

Ambrx raised $45M on August 4, 2016

Investors: Northeast Securities and 国药控股吉林有限公司

A

Ambrx raised $10M on April 1, 2009

Investors: Maverick Ventures, CMEA Capital, M Ventures, Tavistock Group, Versant Ventures, Aravis and 5AM Ventures

A

Ambrx raised $52M on July 5, 2006

Investors: CMEA Capital, Maverick Ventures, Apposite Capital, 5AM Ventures, Tavistock Group, Aravis and Versant Ventures

A

Ambrx raised $5M on January 25, 2006

Investors: Versant Ventures, 5AM Ventures and Tavistock Group

A

Ambrx raised $23M on March 21, 2005

Investors: Maverick Ventures, 5AM Ventures, Versant Ventures and Tavistock Group

A

Ambrx raised $13M on September 25, 2003

Investors: Tavistock Group and 5AM Ventures

FAQ